2020 Special Report: Celebrating 60 Years of the Single Convention on Narcotic Drugs of 1961 and 50 Years of the Convention on Psychotropic Substances of 1971
Bibliography: International Policy Issues
Single programming document 2021–2023
The new Single programming document sets out the EMCDDA’s activities for the period 2021–2023, marking the start of a new five-year roadmap under Strategy 2025
GDS 2020 Key Findings
Download report
Western Hemisphere Drug Policy Commission report
The Western Hemisphere Drug Policy Commission is an independent, bipartisan entity with a two-fold mission: evaluate a range of US counternarcotics programs in the Americas and then make recommendations to improve them
The Impact of Global Drug Policy on Women: Shifting the Needle
Examining the impact of drug criminalisation on a previously overlooked demographic, this book argues that women are disproportionately affected by a flawed policy approach – The ebook edition of this title is Open Access and freely available to read online (emerald insight)
ESPAD Report 2019
The latest European School Survey Project on Alcohol and Other Drugs (ESPAD) report is now available for download
The Global State of Harm Reduction 2020
The Global State of Harm Reduction is the only report that provides an independent analysis of harm reduction in the world (Harm Reduction International)
European Drug Report 2020
2020 European Drug Report, our annual overview of the drug situation in Europe (EMCDDA)
Principles for the responsible legal regulation of cannabis
This Advocacy Note proposes twenty principles that should inform any regulatory framework for cannabis markets, whether for medical or for adult non-medical use. They are arranged in five categories (IDPC)
GDS: the world’s largest drug survey
The GDS Special Edition on COVID-19 was developed as part of a global effort to better understand the impact of the pandemic on people’s lives with a specific focus on the use of alcohol and other drugs, mental health and relationships
WHO cannabis rescheduling and its relevance for the Caribbean
Following its first-ever critical review of cannabis, in January 2019 the World Health Organization (WHO) issued a collection of formal recommendations to reschedule cannabis and cannabis-related substances. 53 member states of the Commission on Narcotic Drugs (CND), two of which are Caribbean states, are set to vote on these recommendations in December 2020 (tni)
The new EU Agenda and Action Plan on Drugs 2021-2025
On the path toward building up its internal security, on 24 July 2020, the European Commission adopted a new EU Agenda and Action Plan on Drugs 2021-2025
World Drug Report 2020
Presented in six separate booklets, the World Drug Report 2020 provides a wealth of information and analysis to support the international community in implementing operational recommendations on a number of commitments made by Member States, including the recommendations contained in the outcome document of the special session of the General Assembly on the world drug problem, held in 2016 (UNODC)
Synthetic Drugs in East and Southeast Asia (PDF)
Latest developments and challenges (UNODC)
NODC report on East and Southeast Asia
Continued growth in the supply of methamphetamine while synthetic opioids spread – Download (UNODC)
The Uruguay – West Africa trafficking connection. An urgent need for closer cooperation and policy exchange (PDF)
Uruguay’s emergence as a transit route for cocaine provides new challenges to international law enforcement cooperation and creates greater need for setting up secure channels of communication between Uruguayan and West African law enforcement (Gdpo)
Trends in the availability and type of drugs sold on the internet via cryptomarkets
January 2019 – January 2020 (NDARC)
Seoul Searching
South Korea’s AI Counter-Cryptomarket Capability and Associated Privacy Dilemmas (gdpo)
A review of legislative initiatives on the liability of drug-related advocacy (propaganda) in Russia, Ukraine, and Kazakhstan during the second half of 2019 and early 2020
possible risks for social programmes aimed at working with people who use drugs (ehra)
EMCDDA publishes update on the implications of COVID-19 for people who use drugs and for drug service providers
What specific risks are people who use drugs (PWUD) likely to face during the COVID-19 pandemic? What services will they need? How will professionals working with this group need to adapt on the frontline? (EMCDDA)
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 13
- Next Page »
